rs1150752
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001365276.2(TNXB):āc.904A>Gā(p.Thr302Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0973 in 1,611,064 control chromosomes in the GnomAD database, including 9,877 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001365276.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNXB | NM_001365276.2 | c.904A>G | p.Thr302Ala | missense_variant | 3/44 | ENST00000644971.2 | NP_001352205.1 | |
TNXB | NM_019105.8 | c.904A>G | p.Thr302Ala | missense_variant | 3/44 | NP_061978.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNXB | ENST00000644971.2 | c.904A>G | p.Thr302Ala | missense_variant | 3/44 | NM_001365276.2 | ENSP00000496448 |
Frequencies
GnomAD3 genomes AF: 0.0624 AC: 9413AN: 150772Hom.: 457 Cov.: 33
GnomAD3 exomes AF: 0.0589 AC: 14500AN: 246382Hom.: 748 AF XY: 0.0579 AC XY: 7752AN XY: 133788
GnomAD4 exome AF: 0.101 AC: 147319AN: 1460176Hom.: 9420 Cov.: 34 AF XY: 0.0975 AC XY: 70835AN XY: 726260
GnomAD4 genome AF: 0.0624 AC: 9410AN: 150888Hom.: 457 Cov.: 33 AF XY: 0.0579 AC XY: 4273AN XY: 73744
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 24, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at